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Abstract 
Macrophages are intimately involved in the pathophysiology of endometriosis, a chronic 
inflammatory disorder characterized by the growth of endometrial-like tissue (lesions) 5 
outside the uterus. By combining genetic and pharmacological monocyte and macrophage 
depletion strategies we determined the ontogeny and function of macrophages in a mouse 
model of induced endometriosis. We demonstrate that lesion-resident macrophages are 
derived from eutopic endometrial tissue, infiltrating large peritoneal macrophages (LpM) 
and monocytes. Furthermore, we found endometriosis to trigger continuous recruitment of 10 
monocytes and expansion of CCR2+ LpM. Depletion of eutopic endometrial macrophages 
results in smaller endometriosis lesions, whereas constitutive inhibition of monocyte 
recruitment significantly reduces peritoneal macrophage populations and increases the 
number of lesions. Re-programming the ontogeny of peritoneal macrophages such that 
embryo-derived LpM are replaced by monocyte-derived LpM decreases the number of 15 
lesions that develop.  We propose a putative model whereby endometrial macrophages are 
‘pro-endometriosis’ whilst newly-recruited monocyte-derived macrophages, possibly in LpM 
form, are ‘anti-endometriosis’. These observations highlight the importance of monocyte-
derived macrophages in limiting disease progression. 
 20 
Significance statement 
Endometriosis is a chronic, incurable inflammatory disorder impacting 190 million women 
worldwide. Immune cells called macrophages are implicated in promoting endometriosis. 
Macrophages have different origins and their origin can dictate function. In this study we 
demonstrate that endometriotic lesion-resident macrophages are derived from the uterine 25 
lining (endometrium), the abdominal (peritoneal) cavity and from recruited bone-marrow 
precursors (monocytes). Endometriosis triggers continuous recruitment of monocytes that 
differentiate into macrophages that differ from those usually present within the peritoneal 
cavity. By depleting different populations, we demonstrate that endometrial macrophages 
are 'pro-endometriosis' whilst monocyte-derived peritoneal macrophages are 'anti-30 
endometriosis' acting to protect the cavity from lesion establishment. In the future immune-
based therapies may allow targeting of pro-disease macrophages and / or harnessing of 




Macrophages are exceptionally diverse cells present in all tissues of the body that 
perform functions vital for immunity, development, tissue homeostasis and repair following 
injury. They modify their role depending on signals received from their local 
microenvironment and accordingly exhibit high degrees of transcriptional and phenotypic 
heterogeneity and tissue-specific function(1, 2).  Macrophages differ in their ontogeny. 40 
Whilst early studies suggested macrophages were continually replaced by circulating blood 
monocytes, more recent lineage-tracing experiments demonstrated that most tissue-
resident macrophages (exceptions include gut, dermis and heart) are derived from 
embryonic precursors that seed tissues prior to birth and are maintained by self-renewal or 
longevity(3-5). Tissue-resident and monocyte-derived macrophages play distinct roles both 45 
in health and disease(6). Usually, tissue-resident macrophages play tissue specific 
homeostatic roles as well as core functions such as clearance of dying cells. On the other-
hand monocyte-derived macrophages that are recruited to tissues during inflammation 
secrete pro-inflammatory cytokines, help clear infection and regulate the immune 
response(6). Thus, in pathological situations, macrophages are a heterogenous population. 50 
For example, during acute liver injury hepatic resident macrophages (Kupffer cells) become 
activated and recruit monocytes that initially promote liver injury, but then subsequently 
differentiate into inflammatory macrophages and help resolve injury and drive 
regeneration(7). In pancreatic cancer, both tissue-resident and monocyte-derived 
macrophages populate the tumor and increase in density as the cancer progresses. The two 55 
populations are transcriptionally diverse and depletion studies revealed that only tissue-
resident macrophages are responsible for driving tumor progression(8). These findings also 
highlight that under disease-modified conditions tissue-resident macrophages can become 
adapted such that they promote disease. Conversely, in other cancers (e.g. breast), 
monocytes are recruited to the tumor and differentiate into tumor-associated macrophages 60 
that drive disease (1).  
The peritoneal cavity hosts two main macrophage populations: a predominant 
population expressing high levels of EGF-like module-containing mucin-like hormone 
receptor-like 1 (EMR1 / F4/80) and low levels of major histocompatibility class II (MHCII) 
known as large peritoneal macrophages (LpM), and a less abundant population that are 65 
F4/80lo, MHCIIhi (small peritoneal macrophages; SpM)(9). LpM are considered to be tissue 
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resident macrophages and are largely embryonically derived, however it is now understood 
that they are gradually replaced by monocytes over time in a sexually dimorphic manner, 
that occurs more quickly in males(10, 11). The transcription factor GATA6 is highly 
expressed by all LpM in response to retinoic acid and drives a significant proportion of the 70 
tissue specific transcriptional signature of these cells(12). The SpM population is a more 
heterogeneous population comprising monocyte-derived macrophages and dendritic cells 
that are continually replenished from the blood(10, 13). Inflammatory challenge in the 
peritoneal cavity can result in recruitment of large numbers of inflammatory macrophages 
that are transcriptionally distinct from SpM(14), and a loss in LpM (the so-called 75 
macrophage disappearance reaction (MDR)), which results from formation of cell 
aggregates(15) or cell death(16). An exception to this is helminth infections which are 
characterized by expansion of LpM in response to local Th2 cytokine production(17) (18-20) 
(21).  
Endometriosis is a chronic inflammatory condition where tissue similar to the 80 
endometrium grows ectopically, usually in the peritoneal cavity as ‘lesions’(22). The 
condition impacts an estimated 190 million women worldwide and is associated with 
debilitating pelvic pain and infertility(23). Currently, therapeutic options are very limited, 
with the gold-standard treatments being surgical removal of lesions or suppression of 
ovarian hormones. Surgery is associated with high recurrence rates and ovarian suppression 85 
is contraceptive and often has unwanted side effects. A high abundance of macrophages is 
reported both in the peritoneal cavity and in lesions of women with endometriosis(24). It is 
clear that macrophages are intrinsically linked with the pathophysiology of endometriosis 
where they enhance establishment, proliferation and vascularisation of lesions(25, 26). They 
are also critical in promoting innervation of lesions and concomitant sensitization of nerve 90 
fibres, thus contributing to pain in the condition(27, 28).  Evidence from a syngeneic mouse 
model of induced endometriosis indicates that donor endometrial macrophages as well as 
host-derived macrophages can be identified in endometriosis lesions(29). However, the 
exact origins of the host-derived macrophages and specific functions of the different 
populations remains to be determined.  95 
Since macrophages play such a key role in many aspects of the pathophysiology of 
endometriosis they represent an attractive therapeutic target. However, the development 
of a viable immune-therapy targeting ‘disease-promoting’ macrophages or enhancing the 
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function of ‘protective’ macrophages requires a comprehensive understanding of the origin 
and function of lesion-resident and associated peritoneal macrophages. In this study we 100 
have characterized the origin of endometriosis lesion-resident macrophages and examined 
the dynamics of peritoneal cavity macrophage populations. Finally, we have used a 
combination of transgenic and pharmacological approaches to selectively deplete different 
populations of macrophages to assess their impact on development of endometriosis 
lesions.  105 
Results 
Endometriosis lesion-resident macrophages have multiple origins. We induced 
endometriosis in wild-type C57BL/6 mice by injecting ‘menses-like’ endometrium from 
MacGreen donor mice (Csf1r-eGFP, macrophages are GFP+)(30) into the peritoneal cavity as 
previously described(29). In MacGreen mice all monocytes and macrophages in the shed 110 
menses-like endometrium are GFP+(31). Two weeks following tissue injection, 
endometriosis lesions were collected, digested and analysed by flow cytometry. GFP+ 
macrophages could be detected among cluster of differentiation (CD)45+, lineage- (CD3, 
CD19, CD335, Sialic acid-binding immunoglobulin-type lectin F (SIGLEC-F)), Lymphocyte 
antigen 6 complex, locus G6D (Ly6G)-, Integrin alpha M (CD11b)+ lesion cells (Fig.1A). These 115 
data indicate that macrophages derived from the donor endometrium reside within lesions 
and verifies our previous findings using immunodetection(29). Endometrial-derived 
macrophages (GFP+) represented 16.0% (standard deviation (SD) ± 8.6) of lesion-resident 
macrophages, whilst the remaining 84.0% (GFP-; SD ± 8.4) were host-derived infiltrating 
populations (Fig.1B). Next, we sought to determine the origin of the host-derived infiltrating 120 
cells. We investigated infiltration of LpM into endometriosis lesions using dual 
immunodetection for F4/80 (red) and the transcription factor GATA binding protein 6 
(GATA6; LpM marker, green; Fig.1C). Quantification of dual positive cells revealed that less 
than 1.0% of lesion-resident cells were derived from LpM (Fig.1D). To verify these findings, 
we performed adoptive transfer of GFP+ LpM isolated by fluorescent activated cell sorting 125 
(FACS) from MacGreen mice (LpM and SpM were determined based on expression of F4/80 
and MHCII; see below). GFP+ macrophages could be easily detected in lesions (Fig.1E) 
suggesting that LpM infiltrate endometriosis lesions and lose expression of GATA6, 
consistent with a change in phenotype within the lesion microenvironment. Conversely, 
very few GFP+ macrophages were detected in lesions following adoptive transfer of SpM 130 
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isolated from MacGreen mice, suggesting that significant trafficking of peritoneal 
macrophages to lesions was restricted to the LpM population (Fig.1F). Interestingly, GFP+ 
SpM were instead observed located to the peritoneum adjacent to lesions. Quantification of 
GFP immunofluorescence revealed that a mean of 27.4% of cells in lesions were derived 
from LpM and a mean of 3.6% were derived from SpM (Fig.1G). To assess infiltration of 135 
monocytes into lesions we used dual immunodetection for F4/80 (red) and Lymphocyte 
antigen 6 complex, locus C (Ly6C; green). We identified Ly6C positive lesion-resident 
monocytes and a population of dual positive cells (yellow) were also detected indicating 
that monocytes infiltrated lesions and differentiated in situ into macrophages (Fig.1H).  
Continuous recruitment and contribution of monocytes to peritoneal macrophage 140 
populations in mice with induced endometriosis. Next, we investigated macrophage 
populations present in the peritoneal cavity of mice with induced endometriosis. From 
CD45+, Ly6G-, lineage- cells, LpM and SpM were determined based on expression of F4/80 
and MHCII (Fig.2A). At one-week post tissue injection, LpM (F4/80hi, MHCIIlo) numbers were 
significantly higher in sham mice (ovariectomized and treated with estradiol valerate and 145 
subject to intra-peritoneal (i.p) injection of PBS instead of endometrial tissue) compared to 
naïve mice (mean  SEM = 48399  7361 cells/ μl in sham and 18969  5989 cells/ μl in 
naïve; Fig.2B; p<0.01). At three weeks, LpM numbers in sham animals had decreased 
compared to one-week  (p<0.05). In contrast, no significant differences were found in the 
LpM population in mice with endometriosis compared to naïve and sham animals or within 150 
the endometriosis group at different timepoints. However, a trend can be observed 
indicating a moderate decrease in LpM numbers at one-week post-tissue injection in 
endometriosis mice compared to sham. This suggests that, compared to sham controls, 
there may be some loss of LpM following transfer of endometrial tissue, and this could be 
attributed to LpM trafficking into lesions or possible clotting of LpM as seen in peritonitis 155 
models(32). By three weeks the trend toward decreased LpM in endometriosis mice 
compared to sham is no longer evident and is consistent with our previous reports 
demonstrating an increase in LpM at 3 weeks in mice with endometriosis(27). SpM (F4/80lo, 
MHCIIhi) numbers were consistent between all groups of animals and time points. 
Ovariectomy alone can have striking impacts on macrophage pools present in the peritoneal 160 
cavity and leads to increased macrophage replenishment(11). We repeated our results using 
intact recipient mice and confirmed that in this minimally invasive model, there was no 
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distinct shift in the ratio of SpM to LpM, suggesting that transfer of endometrial tissue does 
not disrupt the normal balance of peritoneal macrophages (SI Appendix, Fig.S1A). 
Monocytes in the peritoneal cavity were identified by expression of Ly6C (detection of 165 
classical monocytes; Fig.2C) and numbers were significantly increased in mice with induced 
endometriosis at one-week post tissue injection compared to naïve mice (Fig.2D; p<0.01). 
Monocyte numbers remained elevated between weeks one and three in mice with induced 
endometriosis, suggesting continuing recruitment to the peritoneal cavity as a consequence 
of the presence of endometriotic lesions. To begin to investigate the fate of monocytes 170 
recruited to the peritoneal cavity of mice with induced endometriosis, we evaluated 
expression of C-C chemokine receptor type 2 (CCR2; mediates monocyte chemotaxis/ 
recruitment of monocytes) by F4/80hi (LpM) macrophages in the peritoneal cavity using flow 
cytometry.  Significantly elevated numbers of F4/80+, CCR2+ macrophages were recorded in 
mice with induced endometriosis (Fig.2E-F), suggesting that increased numbers of 175 
monocyte-derived LpM are evident in mice with endometriosis. In steady state conditions, 
long-lived embryo-derived peritoneal macrophages express T-cell immunoglobulin and 
mucin domain containing 4 (TIM4), whilst recently monocyte-derived LpM do not(10), thus 
to further validate our hypothesis we ascertained TIM4 expression in F4/80hi LpM in intact 
mice. We found a significant reduction in TIM4hi LpM at week two and three compared to 180 
week one (Fig.S1B; p<0.05) and a concomitant increase in TIM4lo LpM at week two (p<0.05) 
and three (p<0.01) compared to week one (SI Appendix, Fig.S1B). This finding is consistent 
with heightened monocyte input into the LpM pool in endometriosis. We also observed a 
significant reduction in the proportion of F4/80lo, MHCII- cells within CD11b+ peritoneal 
population between week one and week three post endometrial tissue injection (SI 185 
Appendix, Fig.S1C-D). Only a minor proportion of these cells express Ly6C (less than 2% of 
CD11b cells), indicating that this population may be a transitory state between monocyte 
and LpM. 
Endometrial macrophage depletion leads to reduced endometriotic lesion size. To dissect 
the role of macrophages with different ontogenies in endometriosis we used a number of 190 
depletion strategies. To deplete endometrial macrophages, doxycycline was administered to 
iCsf1r-KO donor mice from day 15-19 post ovariectomy (Fig.3A), such that we could achieve 
macrophage depletion by inducibly ablating expression of Csf1r(33) . Pre-transfer analysis 
revealed that the endometrium was significantly depleted of F4/80hi macrophages (Fig.3B; 
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p<0.05). Following transfer of macrophage-depleted donor endometrial tissue to wild-type 195 
recipients, there was no difference in the number of lesions recovered after two weeks 
(Fig.3C); however the lesions recovered were significantly smaller than those from mice 
receiving wild-type endometrium (Fig.3D; p<0.05).  These data suggest that macrophages 
within endometrial tissue promote the growth of endometriosis lesions but do not 
significantly impact the attachment of endometrial tissue to the peritoneal lining. 200 
‘Monocytopenic’ mice with induced endometriosis had an increased number of lesions. 
Previous studies have inferred a role for recipient peritoneal macrophages in lesion 
development since continual i.p delivery of clodronate liposomes or anti-F4/80 antibody 
throughout the growth phase resulted in smaller lesions(25). Further, i.p transfer of bone 
marrow (BM)-derived macrophages could enhance or inhibit growth dependent on 205 
polarisation of macrophages in vitro prior to transfer(25). However, in addition to embryo-
derived resident peritoneal macrophages, it is possible these methods also deplete 
endometrial macrophages (in transferred endometrial tissue) and recruited monocyte-
derived cells. Notably, these studies showed that liposome-mediated depletion of 
embryonic resident peritoneal macrophages prior to endometrial transplantation did not 210 
significantly effect lesion development(25), suggesting the role of embryonic LpM is, at best 
redundant. Hence, we next aimed to prevent recruitment of host monocytes to the 
peritoneal cavity and lesions using Ccr2 null monocytopenic recipient mice. LpM, SpM and 
monocytes were all significantly reduced in the peritoneal lavage fluid of Ccr2-/- mice with 
induced endometriosis compared to wild-type mice with endometriosis (a reduction of 215 
56.4%, 70.5% and 69.0% in mean values respectively; Fig.4A-E and SI Appendix, Fig.S2A-C). 
This supports the concept that in our mouse model of endometriosis monocytes are 
continually recruited and contribute to the LpM and SpM pools. Furthermore, while lesion 
size was not different between the two groups (Fig.4G), Ccr2-/- mice had significantly more 
lesions (p<0.01) compared to wild-type mice (Fig.4F). This indicates that monocytes or 220 
monocyte-derived macrophages normally protect against establishment of lesions.  To 
validate these findings, we repeated the experiment in Chemokine (C-C motif) ligand 2 null 
(Ccl2-/-) mice. In Ccl2-/- mice with endometriosis, LpM and SpM were significantly depleted 
compared to wild-type mice with endometriosis (a reduction of 37.9% and 69.8% in mean 
values respectively; Fig.5A-C; p<0.05 and SI Appendix, Fig.S2D-F). We observed a 225 
concomitant increase in the number of lesions recovered from Ccl2-/- mice (Fig.5E; p<0.05). 
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Strikingly, Ccr2-/-and Ccl2-/- mice with induced endometriosis were still able to recruit 
Ly6C+ monocytes from the bone marrow to the peritoneal cavity despite monocytes being 
absent in the peritoneal lavage of naïve and sham monocytopenic mice (SI Appendix, 
Fig.S3). Moreover, in lesions recovered from Ccr2-/- and Ccl2-/- mice we could still detect 230 
monocytes using immunodetection (Fig.4H-I and Fig.5G-H) indicating that there is 
redundancy in the CCL2-CCR2 axis in the presence of endometriosis lesions and suggests 
that monocytes may also be recruited via another mechanism.  
Transient depletion of monocytes did not impact establishment of endometriotic lesions. 
Next, we sought to transiently deplete monocytes to ascertain the role of undifferentiated 235 
monocytes in lesion development whilst leaving the peritoneal macrophage populations 
relatively unaltered. We depleted monocytes using a function blocking CCR2 monoclonal 
antibody (MC21) injected into the peritoneal cavity of mice with induced endometriosis. 
Mice were injected with MC21, 6 hours prior to transfer of endometrial tissue, and every 
following day for 4 days (Fig.6A). Compared to a control IgG antibody (MC67), MC21 240 
triggered an expansion of LpM (Fig.6C; p<0.05), did not modify SpM (Fig.6D) and 
significantly reduced the number of monocytes in the peritoneal cavity (Fig.6B and E; 
p<0.05). In mice with induced endometriosis treated with MC21 there was no difference in 
lesion number or size compared to mice treated with control MC67 (Fig.6F-G).  These results 
rule out the possible contribution of recently recruited monocytes to the ‘anti-245 
endometriosis’ function of monocyte-derived cells observed in Fig.4-5. 
Re-programming the ontogeny of macrophages in the peritoneal cavity of mice with 
induced endometriosis leads to reduced lesion size. Next, we aimed to confirm the 
protective role of monocyte-derived LpM against establishment of lesions by 
reprogramming the ontogeny of macrophages in the peritoneal cavity. Seven days following 250 
ovariectomy we depleted peritoneal macrophages using liposomal clodronate and allowed 
19 days (34) for replenishment of the niche from monocytes prior to injection of donor 
endometrial tissue (Fig.7A). Compared to control mice with induced endometriosis, those 
with re-programmed cavities exhibited elevated LpM and SpM (Fig.7C-D, p<0.05 and 
p<0.001 respectively). Moreover, endometriosis mice with re-programmed cavities were 255 
significantly depleted of TIM4hi LpM (a reduction of 82.7% in mean values compared to 
control mice with endometriosis; Fig.7E; p<0.01) consistent with replacement of embryo-
derived LpM with monocyte-derived LpM(10)(34). In mice with re-programmed cavities, the 
 10 
number of lesions that developed was significantly reduced, with 5 mice developing no 
lesions at all (p<0.05; Fig.7F). There was no difference in lesion area in mice with 260 
reprogrammed cavities compared to control mice (Fig.7G). Collectively, these data strongly 
support the concept that monocyte-derived LpM act to protect the peritoneal cavity when 
challenged with ectopic endometrial tissue.  
Discussion  
The pathophysiology of endometriosis remains enigmatic(22). Although immune cell 265 
dysfunction is intrinsically linked with the disorder, our understanding of macrophage 
origins and respective function remains limited compared with other diseases, such as 
cancer(35). As the ontogeny of macrophages in diseased tissue is a key determinant of how 
they respond and contribute to pathogenesis, it is necessary to understand how 
macrophages derived from different sources impact lesion development. In the current 270 
study we have determined, in a mouse model of induced endometriosis, that lesion-resident 
macrophages are derived from the eutopic endometrium, infiltrating LpM and monocytes. 
We have demonstrated that endometriosis triggers continuous recruitment of monocytes to 
the peritoneal cavity and heightened monocyte input into the LpM pool.  We show that 
endometrial macrophages promote the growth but not the establishment of endometriotic 275 
lesions, whereas monocyte-derived LpMs play a protective role against lesion development.  
The contribution of embryonic-derived and monocyte-derived macrophages to the 
‘tissue-resident’ population is different in each tissue(3-5). We previously demonstrated 
that macrophages present in the endometrium can be detected in lesions recovered from 
our model of induced endometriosis(29). However, little is known regarding the ontogeny of 280 
macrophages in the endometrium. In a mouse model of menstruation, utilizing MacGreen 
(Csf1r-EGFP) mice, Cousins et al demonstrated that three populations could be distinguished 
in the endometrium using dual staining for F4/80 and GFP: (1) a population of GFP+, F4/80- 
cells likely to be infiltrating monocytes, (2) a population of GFP+, F4/80+ cells suggestive of 
monocyte-derived macrophages, and finally (3) a population of putative (but not confirmed 285 
with lineage tracing) ‘tissue-resident’ macrophages that are GFP-, F4/80+. The cells were 
localized to areas of breakdown, repair and remodelling, respectively(31). The ‘menses-like’ 
endometrium that we recover from donor mice for transfer into recipient mice is collected 
at the initiation of the ‘break-down’ phase and is most likely to consist of monocytes and 
monocyte-derived macrophages. Moreover, the tissue collected is the ‘decidual’ mass only 290 
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and does not include the compartment of the uterus where putative ‘tissue-resident’ 
macrophages are located. Using an inducible Csf1r-knockout to generate donor 
endometrium we achieved depletion of macrophages (F4/80hi, Ly6Clo) and limited the 
number of monocytes (F4/80lo, Ly6Chi) in the tissue transferred to recipient mice. We did 
not observe any difference in the number of lesions formed between recipient mice that 295 
received wild type or macrophage depleted endometrium, however we did find that the 
lesions recovered were significantly smaller in mice receiving macrophage-depleted 
endometrium, indicating that endometrial macrophages play a critical role in growth of 
lesions. The breakdown phase of the (donor) endometrium is analogous to the initial 
inflammatory phase of the wound healing process where pro-inflammatory macrophages 300 
play a vital role prior to wound repair(36). If we consider endometriotic lesions as chronic 
wounds that do not fully resolve their inflammation, we may presume that the initial 
inflammatory phase begins as the endometrium breaks down during menstruation (or 
within the established lesion during cyclical remodelling) and the repair of the translocated 
endometrium occurs in the peritoneal cavity resulting in the formation of lesions. The 305 
subsequent phase of the tissue repair process is the proliferative phase: in mouse models of 
skin injury, macrophage depletion during this phase resulted in granulation tissue that had 
very few blood vessels and proliferative cells and a significant reduction in wound closure. 
This indicates that macrophages support this phase by promoting endothelial cell survival 
and vascularization which facilitates proliferation(37). We suggest that a similar process 310 
occurs in mice receiving endometrium depleted of monocytes and macrophages and this 
may explain reduced lesion size in recipient mice. Further, previous studies have 
demonstrated that macrophages do not regulate survival or proliferation of uterine 
epithelial, stromal or vascular endothelial cells during the estrus cycle or following 
exogenous supplementation with estradiol and progesterone(38). This evidence supports 315 
the concept that macrophages are implicated in tissue repair after hormone withdrawal or 
injury (e.g. following endometrial shedding and in endometriosis), as opposed to having a 
trophic role under steady-state conditions. 
 The ontogeny of peritoneal macrophages is better characterized. LpM are embryo-
derived, long-lived and undergo self-renewal, however monocytes do continually enter the 320 
peritoneal cavity via CCR2 where they continually replenish the SpM compartment and 
infrequently differentiate into LpM(10). Such replenishment of LpM occurs in a sexually 
 12 
dimorphic manner, occurring more quickly in male compared to female mice who retain 
their embryo-derived LpM for much longer(10, 16), and it is likely that in adult female mice 
of the age used in our studies (10-12 wks) only 10-30% of peritoneal LpM would be derived 325 
from adult monocytes(11, 16). In this study we used ovariectomy and estradiol 
supplementation of recipient animals to allow optimal lesion development. Peritoneal 
surgery increases the contribution of monocytes to the peritoneal LpM however; the 
embryonic component would still be expected to comprise approximately 50% of the 
population at the time of injection of endometrial material. Although monocyte-derived 330 
LpM mostly phenocopy embryo-derived LpM, transcriptomically they exhibit some 
differences. For example, embryo-derived LpM express Timd4, whilst in steady state many 
monocyte-derived LpM do not, or take significant time to do so(10, 11). Notably, the 
number of monocytes and CCR2+ LpM was significantly elevated in the peritoneal cavity of 
mice with induced endometriosis, above levels seen in ovariectomised controls, suggesting 335 
monocytes are continually recruited and contribute to LpM pools during lesion 
development.  
Consistent with a significant input of monocytes to LpM in endometriosis, our most 
striking result was revealed by constitutively limiting monocyte recruitment (using both 
Ccr2-/- and Ccl2-/- mice) and subsequently reducing both LpM and SpM replenishment, 340 
which resulted in mice with induced endometriosis developing significantly more lesions. 
When left unmanipulated, female Ccr2-/- mice normally exhibit equivalent numbers of LpM 
to wild-type controls(10). Thus, we suggest that monocyte-derived macrophages act to 
protect the peritoneal cavity and can limit the establishment of lesions (Fig.8).  
 In monocytopenic mice with endometriosis, a reduction in SpM, LpM as well as 345 
monocytes was observed. Monocytopenic mice also exhibited significantly more lesions, 
indicating that monocyte-derived cells are ‘anti-endometriosis’, although to which 
population of monocyte-derived cells this function can be attributed remains uncertain. As 
transient antibody-mediated depletion of monocytes during the establishment phase failed 
to increase the number of lesions but also left SpM and LpM populations intact, it seems 350 
likely that either SpM or LpM provide a dominant anti-endometriosis effect.  
We determined that a significant proportion of LpM (27.4% of lesion resident cells 
were GFP+ following adoptive transfer of LpM) but not SpM enter endometriosis lesions 
using adoptive transfers; we suggest that these LpM change phenotype in lesions very 
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rapidly because only a few lesion cells positive for both F4/80 and GATA6 (<1%) were 355 
identified using dual staining, whereas LpM in the cavity are almost entirely positive for 
GATA6(12). Aside from identifying peritoneal LpM as a source of macrophages in 
endometriosis lesions, these findings are important because they show that LpM are able to 
re-programme and survive in ectopic tissue, a topic of significant controversy in the field of 
tissue-resident macrophage biology(39, 40). Indeed, our results are consistent with the 360 
reversible expression of GATA6 by LpM in the absence of sustained retinoic acid receptor 
signalling(12) and mirror recent findings that pericardial cavity GATA6+ macrophages lose 
expression of GATA6 following recruitment to areas of ischemic heart disease(41). In the 
same manner, mature F4/80hi GATA6+ peritoneal LpM are reported to traffic directly across 
the mesothelium into the liver following sterile injury. Once in the liver, the macrophages 365 
undergo local proliferation, and up regulation of markers of alternative activation, such as 
Arginase 1 (Arg1) and Retnla. In the absence of peritoneal macrophages, healing was 
significantly delayed(42). Our data suggest that in endometriosis LpM trafficking to lesions 
may play a similar role, perceiving the ectopic tissue as a wound and activating repair 
processes. Interestingly, GATA6 positive macrophages that invade the epicardium from the 370 
pericardial space following experimental myocardial infarction were anti-fibrotic, despite a 
rapid loss of GATA6 expression(41). Fibrosis is a consistent feature of endometriotic 
lesions(43). Whilst eutopic endometrium is able to undergo scar-free healing to restore full 
tissue functionality, when the tissue is translocated to the peritoneal environment fibrotic 
‘repair’ occurs to form lesions. The mechanisms responsible for this are yet to be fully 375 
resolved but pro-repair macrophages have been implicated in the process(44). Thus, it 
seems unlikely that LpMs trafficking into lesions contribute to fibrotic repair, however, the 
ontogeny of macrophages contributing to fibrogenesis in endometriosis remains to be 
determined.  Interestingly, our data suggest that SpM (which likely include both classical 
dendritic cells (cDC)1 and cDC2, with the flow cytometry gates used in our study) may have 380 
a neutral role in the pathophysiology of endometriosis since they neither increased in 
number nor appeared to significantly contribute to the lesion-resident population. 
Moreover, in our final experiment we sought to re-program the peritoneal cavities of mice 
such that embryo-derived LpM were replaced by monocyte-derived LpM. In endometriosis 
mice with reprogrammed cavities significantly fewer lesions developed. Hence, we suggest 385 
it is the monocyte-derived LpM that are protective against development of endometriosis. 
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One limitation of the current study is the inter-experiment variation in lesion 
number and size in wild-type mice. The mouse model of induced endometriosis used in the 
study relies on spontaneous attachment of the donor endometrial tissue to the peritoneal 
lining of recipient mice. This avoids the additional inflammation triggered by suturing (used 390 
in a number of other models). We carefully control the amount of tissue used to inoculate 
recipient mice, and any donor mice that do not mount the appropriate decidual response 
are excluded. One possible cause that may impact the efficacy of endometrial tissue 
attachment is a discrete difference in the immune status of batches of mice. Future studies 
will determine ontogenetic and phenotypic differences in peritoneal macrophages 395 
recovered from mice with varying degrees of endometrial tissue attachment.  
 Our data indicates a key role for monocyte recruitment to the peritoneal cavity and 
ectopic tissue in endometriosis. We readily detected lesion-resident monocytes as well as 
cells that were double positive for both Ly6C and F4/80, but whether this indicates that 
monocytes rapidly differentiate in lesions or that differentiated monocyte-derived 400 
macrophages are recruited from the peritoneal cavity remains unclear. We speculate that 
monocyte-derived cells represent the largest lesion-resident population. However, we 
cannot currently conclude whether these are monocyte-derived LpM or monocytes 
recruited directly to the lesion. If the latter, we do not know whether these come via the 
cavity or through the newly formed vasculature associated with the lesion.  405 
 In a previous study, Bacci et al depleted peritoneal macrophages using liposomal 
clodronate in a mouse model of endometriosis. Depletion of peritoneal macrophages prior 
to transfer of endometrial tissue had no significant impact on lesion establishment and 
growth(25) implying that embryonic-derived LpM are redundant in lesion development. 
Continuous depletion during establishment and growth resulted in significantly smaller 410 
lesions, allowing the authors to conclude that the dominant role for macrophages in 
endometriosis is to promote the development of lesions. It may be presumed that this 
approach has the potential to deplete all monocytes and macrophages including those in 
the transferred endometrial tissue. Thus, in light of our findings that donor endometrial 
macrophages play a significant role in facilitating lesion growth we suggest the findings of 415 
Bacci et al are a consequence of global macrophage depletion. In contrast, our study used 
depletion strategies that target macrophages from different origins. We demonstrate a 
protective role for monocyte-derived macrophages (presumably in LpM form). Similarly, 
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further experiments by Bacci et al demonstrated that i.p transfer of bone marrow (BM)-
derived macrophages could enhance or inhibit growth dependent on polarisation of 420 
macrophages in vitro prior to transfer(25). Further studies will aim to elucidate the exact 
phenotype and mechanism of monocyte-derived LpM in endometriosis.  
Definition of the macrophage populations that reside in diseased tissues is vital for 
understanding macrophage-driven pathology, particularly for endometriosis where little is 
known about the lesion macrophage niche. In the future it may be possible to harness the 425 
protective properties of monocyte-derived macrophages as a potential therapy for women 
with endometriosis. We propose a putative model that in endometriosis, macrophages 
derived from the endometrium exhibit ‘pro-endometriosis’ functions and facilitate growth 
of endometriotic lesions, whereas monocyte-derived cells, possibly in the form of LpM from 
the cavity have an ‘anti-endometriosis’ role and are protective against persistence of 430 
ectopic tissue and establishment of lesions.  
Collectively, we have demonstrated multiple origins for endometriotic lesion-
resident macrophages, a key role for monocyte-derived macrophages in protecting the 
peritoneal cavity when challenged with ectopic endometrial tissue and a pathological role 
for endogenous endometrial macrophages. Our findings imply that monocyte recruitment 435 
or monocyte-derived macrophages may be defective in women with endometriosis, and this 
should be explored in more depth in women with the condition. Thus, we have opened up 
new avenues and possibilities for how macrophages can be targeted or harnessed as a 
therapeutic option in the treatment of endometriosis.  
 440 
Materials and Methods  
Animals and reagents. Wild-type C57BL/6JOIaHsd female mice were purchased from Harlan 
(Harlan Sprague Dawley Inc, Bicester, UK) at 8-12 weeks of age. All transgenic lines used in 
this study were on the C57BL/6 background, and were bred and maintained at the 
University of Edinburgh or the University of Warwick. All animal work was licensed and 445 
carried out in accordance with the UK Home Office Animal Experimentation (Scientific 
Procedures) Act 1986 and the work licensed under PPL 70/8731 (E.G). Mice had access to 
food and water ad libitum and were kept at an ambient temperature and humidity of 21°C 
and 50% respectively. Light was provided 12 hours a day from 7am-7pm.  ROSA26-
rtTA:tetO-Cre:Csf1rflox/flox(33) (colony stimulating factor 1 receptor (Csf1r) conditional 450 
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knock out) allows deletion of Csf1r following treatment with the tetracycline analog 
doxycycline (2μg/ml in 5% sucrose water; Merck) causing CSF1R expressing macrophage 
populations to be depleted. B6.Cg-Tg(Csf1r-EGFP)1Hume/J (MacGreen) express enhanced 
green fluorescent protein (EGFP) under control of the Csf-1r promoter(45). We used a 
number of strategies to selectively deplete different monocyte-derived populations in the 455 
peritoneal cavity and in lesions; 1) B6.129S4-Ccr2tm1Ifc/J (C-C chemokine receptor type 2 
(Ccr2 -/-) mice have a homozygous mutation in the Ccr2 gene(46). They have reduced 
monocytes, monocyte-derived macrophages and small peritoneal macrophages in the 
peritoneal cavity in addition to a low number of circulating Ly6Chi monocytes due to an 
inability for monocytes to extravasate from the bone marrow and from blood vessels. 2) 460 
B6.129S4-Ccl2tm1Rol/J (Chemokine (c-c motif) ligand 2 (Ccl2) -/-) mice possess a mutation in 
the SCYA2 gene encoding the CCL2 ligand. Ccl2-/- mice have normal peritoneal macrophage 
numbers but reduced recruitment of monocytes and monocyte-derived macrophages into 
the peritoneal cavity under inflammatory conditions(47). 3) The monocyte depleting rat 
anti-mouse CCR2 mAb (clone MC21) isotype IgG2b(48) was used for monocyte depletion 465 
experiments (gifted by Prof M. Mack, University Hospital Regensberg). Mice received a daily 
intraperitoneal injection of 20g per mouse of MC21 to prevent infiltration of monocytes 
into the peritoneal cavity. Isotype-matched rat IgG2b control antibody (MC67) was used as a 
control. To reprogram the peritoneal cavities of mice such that embryo-derived LpM were 
replaced with monocyte-derived LpM we administered liposomal clodronate i.p (Encapsula 470 
NanoSciences; 0.0625mg/mouse) and allowed replenishment of the niche from monocytes 
(see below for further details).  
Mouse model of induced endometriosis. Endometriosis was induced in mice using a 
syngeneic model as previous described(29). The model aims to mirror the process of 
‘retrograde menstruation’. In brief, donor mice were induced to undergo a ‘menses’-like 475 
event by removing the ovaries and exposing the mice to a hormonal schedule similar to a 
truncated menstrual cycle and a stimulus that causes the endometrial stromal cells to 
undergo decidualization(49). Following P4 withdrawal the endometrial lining begins to shed.  
4-6hrs after withdrawal of P4 the ‘menses’-like endometrium is collected and injected into 
ovariectomized mice supplemented with estradiol valerate(49). Lesions are recovered that 480 
contain stoma +/- epithelial cells and immune cell influx(29). Unless otherwise stated lesions 
were collected 2 weeks following tissue injection. For clarity, experiments using different 
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pharmacological / transgenic approaches to deplete monocyte / macrophage populations 
and wild-type mice are described: Experiment 1: Endometrial macrophage incorporation 
into lesions. Endometrium from MacGreen donors was injected i.p into wild-type C57BL/6 485 
recipients (n=6 mice). Experiment 2: Incorporation of peritoneal macrophages into lesions. 
LpM (F4/80hi, MHCIIlo) or SpM (F4/80lo, MHCIIhi) were isolated from MacGreen mice using 
fluorescent activated cell sorting (FACs) and adoptively transferred into the peritoneal cavity 
of recipient mice (n=12 per population) at the same time as donor endometrium, both 
donor and recipient were wild-type C57BL/6. Incorporation was evaluated using 490 
immunodetection of GFP. Experiment 3: Impact of endometrial macrophage depletion on 
lesion formation. Macrophages were depleted in donor endometrium by administering 
doxycycline to Csf1r-cKO mice between days 15-19 of the ‘menses’ protocol (Fig.4A). 
Macrophage depleted endometrium was injected i.p into wild-type recipients (n=9). For 
comparison wild-type endometrium was transferred into wild-type recipients (n=10). The 495 
data from 2 independent experiments are presented. Experiment 4: Constitutive depletion 
of monocytes in the peritoneal cavity (i). Donor endometrium from wild-type C57BL/6 mice 
was injected i.p into wild-type (control; n=11) or Ccr2-/- recipients (n=13). Data from 3 
independent experiments are presented.  Experiment 5: Constitutive depletion of monocytes 
in the peritoneal cavity (ii).  Wild-type donor endometrium was injected i.p into wildtype 500 
(controls; n=6) or Ccl2-/- recipients (n=7). Data from 2 independent experiments are 
presented. Experiment 6: Transient depletion of monocytes in the peritoneal cavity. Six 
hours prior to endometrial transfer recipient C57BL/6 mice received i.p injection of a control 
IgG (MC67; n=9) or a function blocking CCR2 mAb (MC21; n=10). Syngeneic donor 
endometrium was then injected i.p into recipients. Mice received daily injections of MC67 505 
or MC21 until day 5 post-tissue injection when mice were culled. Data from 2 independent 
experiments are presented. Experiment 7: Reprogramming macrophage ontogeny in the 
peritoneal cavity. Seven days post ovariectomy C57BL/6 recipient mice received an i.p 
injection of liposomal clodronate (0.0625mg/mouse, n=10) to deplete peritoneal 
macrophages. We then waited 19 days to achieve replenishment of the LpM population 510 
from monocytes(34). Syngeneic endometrial tissue was injected i.p and lesions recovered 
on day 5 post tissue injection. Non-depleted control mice (n=10) were ovariectomised at the 
same time but left unmanipulated until endometriosis tissue transfer. Data from 1 
independent experiment is presented.  In some experiments we used recipients that had 
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not been ovariectomized (intact). Endometrial tissue was generated and injected in the 515 
same way as the standard model. Recipient mice did not receive any hormonal 
manipulation. In both models, mice were culled 14 days post tissue injection (unless 
otherwise stated) and endometriosis lesions and peritoneal lavage were collected. 
Peritoneal lavage was recovered by injecting 7 ml ice-cold DMEM into the peritoneal cavity 
followed by gentle massage and recovery. Lesions were either collected into neutral-520 
buffered formalin for paraffin embedding and immunohistochemical analysis or DMEM for 
flow cytometry analysis.  
Flow cytometry. Endometrium or lesions were dissected, pooled from each mouse and 
placed in 2ml ice-cold DMEM. Tissues were cut into small pieces using a scalpel and digested 
with 1 unit of Liberase DL, 1 unit of Liberase TL and 0.6 mg DNAse enzymes. The tissue and 525 
enzymes were incubated for 45 minutes at 37°C, with vortexing every 5 minutes. Following 
digestion samples were filtered through 100μM filters. Red blood cells were lysed from 
peritoneal lavages and cells derived from the endometrium or lesions, and approx. 106 cells 
per sample were blocked with 0.025mg anti-CD16/32 (clone 93; BioLegend, San Diego, CA, 
USA) and then stained with a panel of antibodies shown in Table 1. BrilliantTM violet stain 530 
buffer was included when required. Fluorescence minus one (FMO) and unstained controls 
were used to validate gating strategies. Just prior to analysis on the flow cytometer, DAPI 
and 123count eBeads (Thermo Fisher Scientific) were added to samples. Samples were 
analysed using an LSRFortessa with FACSDiva software (BD Biosciences) or FACSMelody with 
Chorus software and analysed with FlowJo v.9 software (FlowJo, Ashland, OR, USA). Analysis 535 
was performed on single, live cells determined using forward scatter height vs. area and 
negativity for live/ dead (DAPI or alternative viability dye). For fluorescent activated cell 
sorting, red blood cell lysis, Fc blocking and fluorescent staining was performed as 
previously described and samples sorted into pure cell populations based on cell surface 
marker expression using a FACS Fusion (BD Biosciences). For data where peritoneal 540 
populations are expressed as cells/ μl, absolute counts were calculated using 123 eBeads 
and the equation: absolute count (cells/ µl) = (cell count / eBead count) x eBead batch 
concentration. Final volume for cytofluorimetric analysis was 300 μl. Thus for example, 400 
cells / μl is equal to 1.2 x105 cells per cavity 
Immunofluorescence. Immunofluorescence was performed as previously described(27, 28, 545 
50). In brief, sections were antigen retrieved with heat and pressure (buffers pH 6.0 or pH 
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9.0) or trypsin tablets dissolved in dH2O (for F4/80 antibody; Sigma) and incubated with 
sections for 20 min at 37°C. Sections were blocked for endogenous peroxidase (6% H2O2 in 
methanol) and nonspecific epitopes (species-specific serum diluted 1:5 in Tris-buffered 
saline and 5% bovine serum albumin, or blocking serum from species specific ImmPRESS® 550 
kit; Vector Laboratories) and incubated with primary antibody (Table 2) at 4°C overnight. 
Antibody detection was performed using a secondary antibody conjugated to horseradish 
peroxidase, often from an ImmPRESS® polymer detection kit followed by colour 
development using a tyramide signal amplification system kit with cyanine (Cy)3 or 
fluorescein (1:50 dilution; PerkinElmer, Waltham, MA, USA). For detection of the second 555 
antigen in dual immunofluorescence, sections were boiled in citrate buffer, and the second 
primary antibody applied overnight and detected as above. Nuclei were stained with DAPI 
and sections mounted in Permafluor (Thermo Fisher Scientific). Images were captured on a 
LSM710 confocal microscope and AxioCam camera (Carl Zeiss). Mouse uterus was used as a 
positive control tissue, and negative controls had omission of the primary antibody 560 
Fiji analysis. For cell counting of F4/80, GATA6 dual immunofluorescent stains, 4 random 
images at x63 objective were taken from each lesion and images quantified using Fiji plugin 
‘Cell Counter’. Total nuclei were counted, as well as cells positive for respective markers. 
Values were expressed as % of total DAPI+ cells. The area of H&E stained lesions captured 
using 2.5x magnification was measured in Fiji by setting the scale to a known size (198 pixels 565 
= 500M) and then drawing around boundary of the lesion (excluding peritoneal and 
adipose tissue) and using the ‘measure’ function.  
Definiens analysis. Ly6C, F4/80 dual immunofluorescence was automatically quantified 
using slide scanning and machine learning. Stained tissue sections were imaged on a Zeiss 
Axioscan.Z1 (Carl Zeiss AG, Oberkochen, Germany) at 20x using fluorescence filters 570 
configured for DAPI, FITC, and Cy3.  Whole-slide .czi files were imported into TissueStudio 
2.4 (Definiens AG, Munich, Germany) for automated tissue detection followed by manual 
correction of ROIs to delineate endometriosis lesion, peritoneum, haemorrhage, and 
adipose tissue.  Tissue studio’s built-in nuclear segmentation, using the DAPI channel, was 
applied within these regions to identify cell objects and these objects were then classified as 575 
positive or negative for each channel based on intensity thresholds which were used across 
all samples. 
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Statistical analysis. Statistical analysis was carried out in GraphPad Prism 7.02. Data was 
first analysed for normality using an Anderson Darling normality test. If data were normally 
distributed, either an ANOVA with a Tukey's post-hoc test (more than 2 samples) or a t-test 580 
(2 samples) was performed. If data were not normally distributed, non-parametric tests 
were used; either Kruskal-Wallis with a Dunn's post hoc test (more than 2 samples) or a 
Mann-Whitney U test (2 samples). Statistical significance was reported at p<0.05.   
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Figures legends 745 
Figure 1: Lesion-resident macrophages have different origins.  
Donor endometrial tissue from MacGreen mice was injected into the peritoneal cavity of 
wild-type recipient mice to assess incorporation of endometrial macrophages into lesions. 
Lesions were collected at two weeks post tissue injection in each of the separate studies 
presented in this figure.  750 
 A) Expression of GFP by lesion-resident macrophages recovered from MacGreen (donor) to 
wild-type (recipient) endometrial transfers (n=6).  
B) Quantification of donor endometrial-derived (GFP+) macrophages vs recipient derived 
(GFP-) macrophages. 
Dual immunodetection for identification of large peritoneal macrophages in lesions. 755 
C) Dual immunodetection for F4/80 (red) and GATA6 (green; n=7 mice (10 lesions)). Thick 
arrows indicate dual positive cells and thin arrows indicate GATA6- macrophages.  
D) Quantification of F4/80+, dual positive and GATA6+ cells in lesions. Less than 1% of cells 
were dual positive for F4/80 and GATA6. 
Adoptive transfers of MacGreen peritoneal macrophages into wild-type mice with GFP 760 
immunodetection to assess incorporation of LpM and SpM into lesions.  
E-F) Immunofluorescence for GFP on lesions collected following adoptive transfer of approx. 
1x106 LpM (E) or SpM (F) isolated from MacGreen mice. Curved dotted line indicates the 
boundary between peritoneal and lesion tissue. In E (i) and (ii) show magnified images, in F 
(i) shows a negative control. 765 
G) Quantification of GFP+ LpM and SpM in lesions. 
Dual immunodetection for Ly6C+ monocytes in lesions.  
 25 
H) Dual immunodetection for F4/80 (red) and Ly6C (green) performed on mouse lesions.  
Data are presented as mean with 95% confidence intervals. Statistical significance was 
determined using a Student’s t-test. ***;p<0.001. 770 
 
Figure 2: Monocyte recruitment and replenishment of peritoneal macrophage pools in 
mice with induced endometriosis.  
A) LpM (F4/80hi, MHCIIlo) and SpM (F4/80lo, MHCIIhi) populations in the peritoneal fluid of 
mice.  775 
B) Quantification of LpM and SpM of sham (n=6-8 each timepoint) and endometriosis mice 
at 1 (n=6), 2 (n=8) and 3 weeks (n=16) post endometrial tissue injection compared to naïve 
mice (n=12).  
C) Flow plot indicating gating of monocytes (F4/80lo, Ly6Chi) in peritoneal lavage fluid.  
D) Quantification of monocyte numbers of sham and endometriosis mice at 1, 2, and 3 780 
weeks post tissue injection.  
E) Flow plot demonstrating expression of Ccr2 on F4/80hi macrophages in peritoneal lavage 
fluid from sham vs endometriosis mice (2 weeks post tissue injection).  
F) Quantification of CCR2+, F4/80hi  cells from endometriosis mice (n=5) compared to sham 
(n=4) and naïve (n=4) mice.  785 
Data are presented as mean ± SEM. Statistics where determined using a one-way ANOVA 
and a Tukey post-hoc test, *;p<0.05, **;p<0.01.  
 
Figure 3: Endometrial macrophage depletion impacts lesion size.  
A) Schematic demonstrating timing of doxycycline administration to iCsf1r-KO donor mice. 790 
Donor endometrium was generated in iCsf1r-KO mice, with doxycycline administered to 
donor mice from day 15-19 to deplete endometrial macrophages prior to recovery of 
endometrium and i.p transfer to wild-type recipients. Lesions were recovered 2 weeks post-
tissue injection.  
B) Quantification of F4/80hi, Ly6Clo macrophages and Ly6Chi, F4/80lo monocytes in donor 795 
endometrium from wild-type and iCsf1r-KO mice.  
C) Number of lesions recovered from wild-type recipient mice receiving either wild-type 
(n=10) or iCsf1r-KO endometrium (n=9) (from 2 independent experiments).  
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D) Area of lesions recovered from mice receiving either wild-type or iCsf1r-KO 
endometrium. Data are presented as mean ± SEM or 95% confidence intervals (C). Statistical 800 
significance was determined using a Student’s t-test. *;p<0.05. 
 
Figure 4: ‘Monocytopenic’ mice with induced endometriosis establish more lesions.   
A) Schematic demonstrating experimental design. Wild-type donor endometrium was 
generated as previously shown (Fig.3A) and injected i.p into ovariectomised Ccr2-/- 805 
recipients. Wild-type recipients were also used as controls. Lesions were recovered 2 weeks 
post-tissue injection. 
B) Flow plot indicating gating and number of LpM (F4/80hi) and SpM (MHCIIhi) in peritoneal 
lavage fluid recovered from wild-type (n=7) and Ccr2-/- mice (n=8) with induced 
endometriosis. 810 
C-E) Quantification of (C) LpM, (D) SpM, and (E) monocytes (Ly6Chi) in peritoneal lavage 
fluid. 
F) Number of lesions recovered from wild-type (n=11) and Ccr2-/- (n=13) mice with induced 
endometriosis (from 3 independent experiments). 
G) Size of lesions recovered from wild-type and Ccr2-/- mice with induced endometriosis.  815 
H) Dual immunodetection for Ly6C (green) and F4/80 (red) on lesions recovered from wild-
type and Ccr2-/- mice 
I) Quantification of monocytes (Ly6C+; yellow bars) and monocyte-derived macrophages 
(Ly6C+, F4/80+; green bars) in lesions recovered from wild-type and Ccr2-/- mice. 
Data are presented as mean ± SEM or 95% confidence intervals (F). Statistical significance 820 
was determined using a Student’s t-test or Mann-Whitney test. *;p<0.05, **;p<0.01, 
**;p<0.001. 
 
Figure 5: More lesions are evident in Ccl2-/- mice.  
Wild-type donor endometrium was generated as previously shown (Fig.3A) and injected i.p 825 
into ovariectomised Ccl2-/- recipients as in the previous figure. Wild-type recipients were 
also used as controls. Lesions were recovered 2 weeks post-tissue injection. 
A) LpM and SpM populations in peritoneal lavage fluid from wild-type and Ccl2-/- mice with 
induced endometriosis.  
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(B- D) Quantification of (B) LpM,( C) SpM, and (D) monocytes in peritoneal lavage fluid from 830 
wild-type (n=5) and Ccl2-/- (n=5) mice with induced endometriosis.  
E) Number of lesions recovered from wild-type and Ccl2-/- mice.  
F) Size of lesions recovered from wild-type (n=6) and Ccl2/- (n=7) mice with induced 
endometriosis (from 2 independent experiments).  
G) Dual immunodetection for Ly6C (green) and F4/80 (red) on lesions recovered from wild-835 
type and Ccl2-/- mice 
H) Quantification of monocytes (Ly6C+) and monocyte-derived macrophages (Ly6C+, 
F4/80+) in lesions recovered from wild-type and Ccl2-/- mice. 
Data are presented as mean ± SEM or 95% confidence intervals (E). Statistical significance 
was determined using a Student’s t-test or Mann-Whitney test. *;p<0.05.  840 
 
Figure 6: A function-blocking Ccr2 mAb reduces monocyte numbers without significant 
impact on lesion number.  
A) Schematic showing the experimental design; mice with induced endometriosis were 
treated with a control IgG (MC67; n=9) or a function blocking CCR2 mAb (MC21; n=10, from 845 
2 independent experiments)), 6 hours prior to endometrial tissue injection and daily for an 
additional 4 days. Lesions were recovered 5 days post tissue injection.  
B) Flow plot demonstrating the numbers of Ly6Chi monocytes in mice with induced 
endometriosis treated with MC67 or MC21.  
C-E) Quantification of (C) LpM, (D) SpM, (E) monocytes in the peritoneal lavage fluid of mice 850 
with induced endometriosis. 
F) Number of lesions recovered from mice treated with MC67 or MC21. 
G) Size of lesions recovered from mice treated with MC67 or MC21.   
Data are presented as mean ± SEM or 95% confidence intervals (F). Statistical significance 
was determined using a student’s t-test or a Mann-Whitney test. *;p<0.05. 855 
 
Figure 7: Reprogramming the ontogeny of peritoneal macrophages leads to establishment 
of fewer lesions.  
A) Schematic showing the experimental design; 7 days post ovariectomy experimental mice 
were administered i.p with liposomal clodronate to deplete all peritoneal macrophages 860 
(n=10). Nineteen days were allowed for replenishment of the niche prior to transfer of 
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endometrial tissue on day 26. Lesions were recovered 5 days post tissue injection. Control 
mice (n=10) did not receive liposomal clodronate (single independent experiment).  
B) Flow plot demonstrating the numbers of TIM4hi and TIM4lo LpM in control mice with 
induced endometriosis or mice with re-programed cavities with induced endometriosis.  865 
C-E) Quantification of (C) LpM, (D) SpM, (E) TIM4hi LpM in the peritoneal lavage fluid of mice 
with induced endometriosis. 
F) Number of lesions recovered from control mice and those with re-programed cavities. 
G) Size of lesions recovered from control mice and those with re-programed cavities.   
Data are presented as mean ± SEM or 95% confidence intervals (F). Statistical significance 870 
was determined using a student’s t-test or a Mann-Whitney test. *;p<0.05, **;p<0.01. 
 
Figure 8: Monocyte-derived macrophages are guardians of the peritoneal cavity in mice 
with induced endometriosis.  Created with BioRender.com. 
Lesion-resident macrophages are a heterogenous population constituted by macrophages 875 
that have different origins; endometrial, peritoneal (LpM), and recruited monocytes that 
differentiate into macrophages in lesions. Wild-type mice with induced endometriosis 
exhibit increased monocyte recruitment and replenishment of LpM pools from monocytes. 
In mice where monocyte recruitment is constitutively limited (Ccr2-/- or Ccl2-/-), LpM and 
SpM pools are significantly reduced, consistent with the majority of LpM in the peritoneal 880 
cavity being embryo-derived. In these (monocytopenic) mice, more lesions develop. Mice 
with ontogenetically reprogrammed peritoneal cavities (embryo-derived LpM depleted 
using liposomal clodronate followed by a 19-day replenishment window), develop 
significantly fewer lesions. Collectively, these data suggest that monocyte-derived LpM 
protect the peritoneal cavity when challenged with ectopic endometrial tissue.  We propose 885 
a putative model where endometrial macrophages promote lesion growth, whilst 
monocyte-derived macrophages (possibly monocyte-derived LpM) protect the peritoneal 
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Response to Editor and Reviewers 
 
We thank the editor, editorial board members and reviewers for their consideration of the 
manuscript. Specifically, we thank the editor and the reviewers for their gracious comments about 
the study and reviewer 1 for further recommendations to improve the manuscript. We have now 




Significance statement: The second sentence "macrophages promote endometriosis" is very firm and 
given it is based on data from animal models, I think might be better written as "Macrophages are 
implicated in promoting endometriosis". The 'slash' on the last line would be better as 'and/or'  
 
We have now amended this as the reviewer suggests at line 23 and 32, respectively. 
 
















Line 119: 'host derived' should have a hyphen here and throughout, for consistency  
 
Corrected and checked throughout.  
 




Line 145: statement of data is not clear - would be better to write 'mean + SEM = xxxx + xxx in control 
and xxx + xxx in estradiol valerate-treated females respectively' or similar  
 
We thank the reviewer for pointing this out. We have now corrected this.  
 
Line 215: all percentage values here and elsewhere should have the same number of decimal places  
 
Corrected here and throughout.  
 




Line 262: 'act as guardians' is unscientific - better as 'act to guard against' or 'act to protect against'  
 
Amended at line 258. 
 
Line 311: remove hyphen in 'endometrium-depleted'  
 
Corrected at line 305. 
 
Discussion: It would be helpful to add a sentence to acknowledge the high degree of between 
experiment variation as limitation of the model, and to suggest potential reasons for the high 
variance between experimental runs.  
 
We have added an additional paragraph to the discussion at line 375 that highlights the limitation 
and discusses a possible reason for this and future directions.  
 
Discussion lines 295-305: Reviewer #2 raises the question of possible trophic roles of macrophages in 
eutopic endometrium. This possibility has been examined by Care et al., "Ovarian Steroid Hormone-
Regulated Uterine Remodeling Occurs Independently of Macrophages in Mice" Biology of 
Reproduction, Volume 91, Issue 3, 1 September 2014, 60, 1-
12, https://doi.org/10.1095/biolreprod.113.116509 and other publications from the same authors. 
Using a CD11b-dtr macrophage depletion model, the authors found macrophages do not regulate 
survival or proliferation in uterine epithelial, stromal or vascular endothelial cells in the estrous cycle 
or after decidualisation. This might be cited as additional evidence to support the inference in lines 
295-305 that macrophages are implicated in tissue recovery and remodelling after hormone 
withdrawal or injury, as opposed to tissue generation and homeostasis.  
 
We thank the reviewer for this suggestion which links nicely in the discussion. We have added 
details and citation to line 307. 
